UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Single and Combined Silencing of ERK1 and ERK2 Reveals Their Positive Contribution to Growth Signaling Depending on Their Expression Levels

Molecular and Cellular Biology, 2008-01, Vol.28 (1), p.511-527

2008

Volltextzugriff (PDF)

Total ERK1/2 activity regulates cell proliferation

Cell cycle (Georgetown, Tex.), 2009-03, Vol.8 (5), p.705-711

2009

Volltextzugriff (PDF)

ERK Nuclear Translocation Is Dimerization-independent but Controlled by the Rate of Phosphorylation

The Journal of biological chemistry, 2010-01, Vol.285 (5), p.3092-3102

2010

Volltextzugriff (PDF)

TRB3 Inhibits the Transcriptional Activation of Stress-regulated Genes by a Negative Feedback on the ATF4 Pathway

The Journal of biological chemistry, 2007-05, Vol.282 (21), p.15851-15861

2007

Volltextzugriff (PDF)

Inhibition of B56-containing Protein Phosphatase 2As by the Early Response Gene IEX-1 Leads to Control of Akt Activity

The Journal of biological chemistry, 2007-02, Vol.282 (8), p.5468-5477

2007

Volltextzugriff (PDF)

ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?

Frontiers in cell and developmental biology, 2016-06, Vol.4, p.53-53

2016

Volltextzugriff (PDF)

The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases

Journal of cell science, 2001-10, Vol.114 (Pt 19), p.3433-3443

2001

Volltextzugriff (PDF)

ERK implication in cell cycle regulation

Biochimica et biophysica acta, 2007-08, Vol.1773 (8), p.1299-1310

2007

Volltextzugriff (PDF)

p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol

Oncogene, 2002-09, Vol.21 (42), p.6413-6424

2002

Volltextzugriff (PDF)

N-terminal alanine-rich (NTAR) sequences drive precise start codon selection resulting in elevated translation of multiple proteins including ERK1/2

Nucleic acids research, 2023-08, Vol.51 (15), p.7714-7735

2023

Volltextzugriff (PDF)

Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling

Biochemical pharmacology, 2002-09, Vol.64 (5-6), p.755-763

2002

Volltextzugriff (PDF)

Oncogenic Raf-1 Activates p70 S6 Kinase via a Mitogen-activated Protein Kinase-independent Pathway

The Journal of biological chemistry, 1996-06, Vol.271 (26), p.15762-15768

1996

Volltextzugriff (PDF)

Fidelity and spatio‐temporal control in MAP kinase (ERKs) signalling: Delivered on 24 October 2002 at the 28th FEBS Meeting in Istanbul

European journal of biochemistry, 2003-08, Vol.270 (16), p.3291-3299

2003

Volltextzugriff (PDF)

P2RX7B is a new theranostic marker for lung adenocarcinoma patients

Theranostics, 2020-01, Vol.10 (24), p.10849-10860

2020

Volltextzugriff (PDF)

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

Theranostics, 2019-01, Vol.9 (3), p.661-675

2019

Volltextzugriff (PDF)

ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1

BMC evolutionary biology, 2015-09, Vol.15 (1), p.179, Article 179

2015

Volltextzugriff (PDF)

Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry

The EMBO journal, 1999-02, Vol.18 (3), p.664-674

1999

Volltextzugriff (PDF)

Fidelity and spatio‐temporal control in MAP kinase (ERKs) signalling

European Journal of Biochemistry, 2003-08, Vol.270 (16), p.3291-3299

2003

Volltextzugriff (PDF)

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

Theranostics, 2019, Vol.9 (3), p.661-675

2019

Volltextzugriff (PDF)

Growth factors induce nuclear translocation of MAP kinases (p42(mapk) and p44(mapk)) but not of their activator MAP kinase kinase (p45(mapkk)) in fibroblasts

The Journal of cell biology, 1993-09, Vol.122 (5), p.1079

1993

Volltextzugriff (PDF)

Growth Factors Induce Nuclear Translocation of MAP Kinases (p42mapkand p44mapk) but Not of Their Activator MAP Kinase Kinase (p45mapkk) in Fibroblasts

The Journal of cell biology, 1993-09, Vol.122 (5), p.1079-1088

1993

Volltextzugriff (PDF)

Endosulfan decreases cell growth and apoptosis in human HaCaT keratinocytes: Partial ROS-dependent ERK1/2 mechanism

Journal of cellular physiology, 2007-10, Vol.213 (1), p.177-186

2007

Volltextzugriff (PDF)

Growth Factor-Induced p42/p44 MAPK Nuclear Translocation and Retention Requires Both MAPK Activation and Neosynthesis of Nuclear Anchoring Proteins

The Journal of cell biology, 1998-08, Vol.142 (3), p.625-633

1998

Volltextzugriff (PDF)

Activation of ERK, Controlled by Rac1 and Cdc42 via Akt, Is Required for Anoikis

Annals of the New York Academy of Sciences, 2002-11, Vol.973 (1), p.145-148

2002

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(79)
Mit Volltextzugriff
(78)

Publikationsform

Sprache

Englisch
(88)
Französisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Life Sciences & Biomedicine
(57)
Humans
(32)
Animals
(27)
Life Sciences
(26)
Biological And Medical Sciences
(22)
Biochemistry & Molecular Biology
(17)
Cell Biology
(14)
Male
(13)
Fundamental And Applied Biological Sciences. Psychology
(11)
Medical Sciences
(11)
Female
(10)
Phosphorylation
(10)
Signal Transduction
(10)
Cell Line
(9)
Mice
(9)
Aged
(8)
Cancer
(8)
Cricetinae
(8)
Middle Aged
(8)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Single and Combined Silencing of ERK1 and ERK2 Reveals Their Positive Contribution to Growth Signaling Depending on Their Expression Levels

Total ERK1/2 activity regulates cell proliferation

ERK Nuclear Translocation Is Dimerization-independent but Controlled by the Rate of Phosphorylation

TRB3 Inhibits the Transcriptional Activation of Stress-regulated Genes by a Negative Feedback on the ATF4 Pathway

Inhibition of B56-containing Protein Phosphatase 2As by the Early Response Gene IEX-1 Leads to Control of Akt Activity

ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?

The nucleus, a site for signal termination by sequestration and inactivation of p42/p44 MAP kinases

ERK implication in cell cycle regulation

p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol

N-terminal alanine-rich (NTAR) sequences drive precise start codon selection resulting in elevated translation of multiple proteins including ERK1/2

Fidelity and spatio-temporal control in MAP kinase (ERKs) signalling

Oncogenic Raf-1 Activates p70 S6 Kinase via a Mitogen-activated Protein Kinase-independent Pathway

Fidelity and spatio‐temporal control in MAP kinase (ERKs) signalling: Delivered on 24 October 2002 at the 28th FEBS Meeting in Istanbul

P2RX7B is a new theranostic marker for lung adenocarcinoma patients

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

ERK1 and ERK2 present functional redundancy in tetrapods despite higher evolution rate of ERK1

Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry

Fidelity and spatio‐temporal control in MAP kinase (ERKs) signalling

VEGFC acts as a double-edged sword in renal cell carcinoma aggressiveness

Growth factors induce nuclear translocation of MAP kinases (p42(mapk) and p44(mapk)) but not of their activator MAP kinase kinase (p45(mapkk)) in fibroblasts

Growth Factors Induce Nuclear Translocation of MAP Kinases (p42mapkand p44mapk) but Not of Their Activator MAP Kinase Kinase (p45mapkk) in Fibroblasts

Endosulfan decreases cell growth and apoptosis in human HaCaT keratinocytes: Partial ROS-dependent ERK1/2 mechanism

Growth Factor-Induced p42/p44 MAPK Nuclear Translocation and Retention Requires Both MAPK Activation and Neosynthesis of Nuclear Anchoring Proteins

Systems biologists seek fuller integration of systems biology approaches in new cancer research programs

Activation of ERK, Controlled by Rac1 and Cdc42 via Akt, Is Required for Anoikis

Suchergebnisse filtern